Qiming U.S. Ventures Management, LLC Portfolio Holdings

Qiming U.S. Ventures Management, LLC

  • $0
  • Q3 2025

Qiming U.S. Ventures Management, LLC has filed its 13F form on November 10, 2025 for Q3 2025 where it was disclosed a total value porftolio of $0 distributed in 4 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jasper Therapeutics Inc with a value of $0, Kezar Life Sciences Inc with a value of $0, Korro Bio Inc with a value of $0, and Tourmaline Bio Inc with a value of $0.

Examining the 13F form we can see an decrease of $1.62M in the current position value, from $1.62M to 0.

Below you can find more details about Qiming U.S. Ventures Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Jasper Therapeutics Inc
-
$0 100.0% of portfolio
-
Q1 2024 New
Kezar Life Sciences Inc
-
$0 100.0% of portfolio
-
Q4 2024 New
Korro Bio Inc
-
$0 100.0% of portfolio
-
Q4 2023 New
Tourmaline Bio Inc
-
$0 100.0% of portfolio
-
Q1 2024 Added 15.58%

Summary

  • Portfolio
  • No. of Stocks 4
  • Current Value $0
  • Prior Value $1.62 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 10, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Qiming U.S. Ventures Management, LLC Portfolio

Follow Qiming U.S. Ventures Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qiming U.S. Ventures Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qiming U.S. Ventures Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email